Dyspepsia: An Integrated Review of Diagnosis, Classification, and Mechanisms of Modern and Herbal Medications

Dyspepsia is a common and complex disorder characterized by symptoms such as epigastric pain, bloating, and early satiety, which significantly impact patients' quality of life. The pathophysiology of dyspepsia remains poorly understood, with multiple underlying factors including Helicobacter pylori infection, gastric motility disturbances, and visceral hypersensitivity. Modern therapeutic strategies primarily focus on acid suppression and motility enhancement, with Proton Pump Inhibitors (PPIs), H2 blockers, and prokinetic agents as standard treatments. The advent of novel therapies, such as potassium-competitive acid blockers (P-CABs) like Tegoprazan, offers promising alternatives with faster onset and longer-lasting effects. Herbal therapies, including turmeric, ginger, and licorice, have also been explored, showing potential benefits in symptom relief and gastric protection. Despite these advances, the effectiveness of treatment remains variable, and a tailored approach based on patient-specific factors is recommended. This review highlights the current treatment modalities, including both modern and traditional approaches, with a focus on pharmacological and non-pharmacological therapies for dyspepsia.

Authors

Publication Details

Journal
Majalah Farmaseutik
Published
2026-03-31
DOI
https://doi.org/10.22146/farmaseutik.v22i1.105933
Primary Topic
Helicobacter pylori-related gastroenterology studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dyspepsia: An Integrated Review of Diagnosis, Classification, and Mechanisms of Modern and Herbal Medications

Soni Siswanto, Citra Kurnia Solihat
Majalah Farmaseutik
Helicobacter pylori-related gastroenterology studies
article

Dyspepsia: An Integrated Review of Diagnosis, Classification, and Mechanisms of Modern and Herbal Medications

Soni Siswanto, Citra Kurnia Solihat
article en

Abstract

Dyspepsia is a common and complex disorder characterized by symptoms such as epigastric pain, bloating, and early satiety, which significantly impact patients' quality of life. The pathophysiology of dyspepsia remains poorly understood, with multiple underlying factors including Helicobacter pylori infection, gastric motility disturbances, and visceral hypersensitivity. Modern therapeutic strategies primarily focus on acid suppression and motility enhancement, with Proton Pump Inhibitors (PPIs), H2 blockers, and prokinetic agents as standard treatments. The advent of novel therapies, such as potassium-competitive acid blockers (P-CABs) like Tegoprazan, offers promising alternatives with faster onset and longer-lasting effects. Herbal therapies, including turmeric, ginger, and licorice, have also been explored, showing potential benefits in symptom relief and gastric protection. Despite these advances, the effectiveness of treatment remains variable, and a tailored approach based on patient-specific factors is recommended. This review highlights the current treatment modalities, including both modern and traditional approaches, with a focus on pharmacological and non-pharmacological therapies for dyspepsia.

Majalah FarmaseutikVol. 22(1)
Openalex Percentile: Top 41%
Helicobacter pylori-related gastroenterology studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.